• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Relationship of mildly increased albuminuria and coronary artery revascularization outcomes in patients with diabetes
ConclusionsMildly increased albuminuria is a significant predictor of all ‐cause mortality in those with type‐II diabetes mellitus and stable coronary artery disease, as well as for cardiovascular events those who are nonwhites.
Source: Catheterization and Cardiovascular Interventions - November 23, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Ayesha Siddique, Timothy P. Murphy, Syed S. Naeem, Efaza U. Siddiqui, Karol M. Pencina, Gregory E. McEnteggart, Frank W. Sellke, Lance D. Dworkin Tags: CORONARY ARTERY DISEASE Source Type: research

PFO closure: End of an era or beginning of a new chapter?
Key Points This large long‐term retrospective cohort study shows that percutaneous patent foramen ovale (PFO) closure is safe. Higher rates of recurrent stroke or TIA were noted in older patients (age>55) and those with diabetes and hypertension Randomized trials have failed to show significant benefit from PFO closure for cryptogenic stroke though pooled analyses and longer‐term follow‐up have revealed significant reduction in recurrent strokes. Future studies and longer‐term follow‐up will need to elucidate which subgroups of patients will benefit from closure.
Source: Catheterization and Cardiovascular Interventions - January 23, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Mahmoud I. Traina, E. Murat Tuzcu Tags: Editorial Comment Source Type: research

Sex ‐Based Differences In Outcomes With Bivalirudin Or Unfractionated Heparin For Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial
Conclusions: There was no difference in early outcomes with bivalirudin versus UFH in men or women undergoing contemporary TAVR. This article is protected by copyright. All rights reserved.
Source: Catheterization and Cardiovascular Interventions - June 30, 2016 Category: Cardiovascular & Thoracic Surgery Authors: A Asgar, J Chandrasekhar, G Mikhail, J Webb, T Lefevre, C Tamburino, D Hildick ‐Smith, R Hambrecht, E Van Belle, J Widder, N Dumonteil, U Hink, R Jeger, A Linke, E Dellargyris, P Gao, R Mehran, C Hengstenberg, P Anthopoulos, G Dangas, Tags: Original Studies Source Type: research

Sex ‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study
ConclusionWomen ≤ 55 years of age undergoing ACS PCI have significantly greater comorbidities than young men. Despite a higher risk clinical phenotype in women, prasugrel use was significantly lower in women than men. Female sex was associated with a significantly higher risk of 1‐year MACE and bleeding than male sex, findings that are attributable to baseline differences. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - May 23, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Michela Faggioni, Melissa Aquino, Annapoorna Kini, William Weintraub, Sunil Rao, Samir Kapadia, Sandra Weiss, Craig Strauss, Catalin Toma, Brent Muhlestein, Anthony DeFranco, Mark Effron, Stuart Keller, B Tags: Coronary Artery Disease Source Type: research

Sex‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS Study
Conclusion: Women younger than 55 years of age undergoing ACS PCI have significantly greater comorbidities than young men. Despite a higher risk clinical phenotype in women, prasugrel use was significantly lower in women than men. Female sex was associated with a significantly higher risk of 1‐year MACE and bleeding than men, findings that are attributable to baseline differences. This article is protected by copyright. All rights reserved.
Source: Catheterization and Cardiovascular Interventions - May 5, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Michela Faggioni, Melissa Aquino, Annapoorna Kini, William Weintraub, Sunil Rao, Samir Kapadia, Sandra Weiss, Craig Strauss, Catalin Toma, Brent Muhlestein, Anthony DeFranco, Mark Effron, Stuart Keller, B Tags: Original Studies Source Type: research

Sex‐Based Differences In Outcomes With Bivalirudin Or Unfractionated Heparin For Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial
Conclusions: There was no difference in early outcomes with bivalirudin versus UFH in men or women undergoing contemporary TAVR. This article is protected by copyright. All rights reserved.
Source: Catheterization and Cardiovascular Interventions - April 30, 2016 Category: Cardiovascular & Thoracic Surgery Authors: A Asgar, J Chandrasekhar, G Mikhail, J Webb, T Lefevre, C Tamburino, D Hildick‐Smith, R Hambrecht, E Van Belle, J Widder, N Dumonteil, U Hink, R Jeger, A Linke, E Dellargyris, P Gao, R Mehran, C Hengstenberg, P Anthopoulos, G Dangas, Tags: Original Studies Source Type: research

Long ‐term follow‐up after PFO device closure
ConclusionsDevice closure of PFO can be performed safely with very good long‐term resolution of atrial shunting. Recurrent neurologic events after PFO closure may reflect additional comorbid risk factors unrelated to the potential for paradoxical embolism. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Nathaniel W. Taggart, Guy S. Reeder, Ryan J. Lennon, Joshua P. Slusser, Monique A. Freund, Allison K. Cabalka, Frank Cetta, Donald J. Hagler Tags: Valvular and Structural Heart Diseases Source Type: research

Long‐term follow‐up after PFO device closure
ConclusionsDevice closure of PFO can be performed safely with very good long‐term resolution of atrial shunting. Recurrent neurologic events after PFO closure may reflect additional comorbid risk factors unrelated to the potential for paradoxical embolism. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Nathaniel W. Taggart, Guy S. Reeder, Ryan J. Lennon, Joshua P. Slusser, Monique A. Freund, Allison K. Cabalka, Frank Cetta, Donald J. Hagler Tags: Valvular and Structural Heart Diseases Source Type: research

Thin strut bare metal stents in patients with atrial fibrillation: Is there still a need for BMS?
ConclusionBare metal stenting in AF patients delivered acceptably low TLR and MACE rates while having the benefit of a significantly shorter DAPT duration in a DES dominated clinical practice. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 9, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Matthias Leschke, Matthias Waliszewski, Maxime Pons, Stanislas Champin, Lyassine Nait Saidi, Tay Mok Heang, Oteh Maskon, Wan Azman Bin Wan Ahmad, Denny Herberger, Marc‐Eric Moulichon, Jérôme Rischner, Christophe Robin, Florence Leclercq, Jean‐Pascal Tags: Coronary Artery Disease Source Type: research

Impact of Glomerular filtration rate on clinical outcomes after carotid artery revascularization in 11,832 patients from the CARE registry
ConclusionsPatients with CKD have a greater number of comorbidities and worse unadjusted in‐hospital and 30‐day outcomes; CKD was not, however, an independent predictor of in‐hospital and 30‐day outcomes after carotid artery revascularization. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - May 3, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Luis Gruberg, Allen Jeremias, John H. Rundback, H. Vernon Anderson, John A. Spertus, Kevin F. Kennedy, Kenneth A. Rosenfield Tags: Original Studies Source Type: research

Five‐year clinical follow‐up of a randomized comparison of a polymer‐free sirolimus‐eluting stent versus a polymer‐based paclitaxel‐eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial)
Conclusion At 5 years of follow‐up, clinical outcome was similar between the polymer‐free sirolimus‐eluting Yukon Choice stent and the polymer‐based paclitaxel‐eluting Taxus Liberté stent. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - July 19, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Thomas Stiermaier, Anja Heinz, Denis Schloma, Klaus Kleinertz, Wilfried Dänschel, Sandra Erbs, Axel Linke, Enno Boudriot, Bernward Lauer, Gerhard Schuler, Holger Thiele, Steffen Desch Tags: Original Study Source Type: research

Impact of glomerular filtration rate on clinical outcomes following carotid artery revascularization in 11,832 patients from the care registry®
Conclusions: CKD patients have a greater number of comorbidities, and worse unadjusted in‐hospital and 30‐day outcomes, CKD was not, however, an independent predictor of in‐hospital and 30‐day outcomes after carotid artery revascularization. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - July 1, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Luis Gruberg, Allen Jeremias, John H. Rundback, H. Vernon Anderson, John A. Spertus, Kevin F. Kennedy, Kenneth A. Rosenfield Tags: Original Study Source Type: research